Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
RESEARCH TOOLSreports
TransCode Therapeutics (RNAZ) Ownership - Who Owns TransCode Therapeutics?
211 Followers
TransCode Therapeutics (RNAZ) Ownership Overview
3.57% Insiders
0.02% Mutual Funds
0.53% Other Institutional Investors
95.88% Public Companies and
Individual Investors
The ownership structure of TransCode Therapeutics (RNAZ) stock is a mix of institutional, retail and individual investors. Approximately 0.55% of the company’s stock is owned by Institutional Investors, 3.57% is owned by Insiders and 95.88% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 02, 2023 | Robert Michael Dudley Ceo,director | xxxxxxxxxxxxx | $49980 |
| Oct 02, 2023 | Thomas A Fitzgerald Interim Ceo, Cfo,director | xxxxxxxxxxxxx | $25169 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,502 | Institution | 0.02% | 1,245 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,502 | Institution | 0.02% | 1,245 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns TransCode Therapeutics (RNAZ)?
According to the latest TipRanks data, approximately 0.53% of the company's stock is held by institutional investors, 3.57% is held by insiders, and 95.88% is held by retail investors.
What percentage of TransCode Therapeutics (RNAZ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.53% of TransCode Therapeutics (RNAZ) stock is held by institutional investors.
What percentage of TransCode Therapeutics (RNAZ) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.88% of TransCode Therapeutics (RNAZ) stock is held by retail investors.
Who owns the most shares of TransCode Therapeutics (RNAZ)?
Fidelity Concord Street Trust owns the most shares of TransCode Therapeutics (RNAZ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.